Life sciences · Preprint
arXiv · September 24, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
A central goal when designing treatment policies is often to "do no harm", that is, to avoid interventions that improve average outcomes while worsening outcomes for some individuals. A widely used notion for harm is the fraction of negatively affected (FNA), defined as the probability that an intervention decreases an individual's outcome. However, in many applications, treatments operate through mediators, and a single "total" FNA can obscure whether harm arises primarily through direct pathways or indirect (mediator-induced) pathways. In this work, we introduce a path-specific analogue of the FNA. For this, we disentangle total harm into direct and indirect harm in causal mediation settings. However, these quantities depend on joint distributions of potential outcomes that are not point-identified even in randomised controlled trials. As a remedy, we develop a novel partial identification framework for direct and indirect FNA. In our framework, we (i) derive sharp Makarov bounds for the FNA, and (ii) propose a semiparametrically efficient estimator with valid confidence intervals for these bounds under mild margin conditions. We demonstrate our framework across various numerical experiments. To the best of our knowledge, we are the first to study path-specific decomposition of causal harm and to develop an orthogonal inference framework for its analysis.